AI reads Single-Lead ECG to predict AFib with rapid heart rate within two hours

NCT ID NCT07722039

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence software called SMD-RVECG can predict the risk of atrial fibrillation with rapid ventricular response (a fast, irregular heart rhythm) within the next two hours. Researchers will analyze 348 existing single-lead electrocardiogram recordings from a hospital database. The AI's predictions will be compared to a reference standard set by two doctors to see how accurate it is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an artificial intelligence software called SMD-RVECG that analyzes single-lead electrocardiogram data
What this could lead to
If it works, this AI could help doctors quickly identify patients at risk of a dangerous heart rhythm episode, enabling earlier intervention.
What could go wrong
This is a retrospective study using existing data, not a real-time test. The AI may not perform as well in live clinical settings or on different patient populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.